Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Primus telecommunications, Verizon, Morgan Stanley

Thu, 18th Apr 2013 18:09

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t)

April 18 (Reuters) - Some U.S. stocks on the move onThursday:

WALL ST SLIDES FURTHER, UPTREND IN PERIL

Stocks fell after data showed signs of slower growth aheadfor the U.S. economy, with traders zoning in on technicals toanticipate the market's next move. The Dow Jones industrialaverage fell 52.19 points or 0.36 percent, to 14,566.40,the S&P 500 lost 6.82 points or 0.44 percent, to 1,545.19and the Nasdaq Composite dropped 26.03 points or 0.81percent, to 3,178.64.

** VERIZON COMMUNICATIONS INC, $51.28, up 3.5 pct(1339 ET)

The telephone company reported a higher-than-expectedfirst-quarter profit, driven by strength in its wirelessbusiness.

** MORGAN STANLEY, $20.51, down 4.5 pct (1339 ET)

The sixth-largest U.S. bank by assets said revenue fromcommodities trading fell sharply in the first quarter and it wasworking to dispose of nonessential commodity businesses.

** OVERSTOCK.COM INC, $15.23, up 33 pct (1357 ET)

The discount e-retailer reported a 19 percent jump inrevenue helped by higher average order size. Gross profit in thequarter also improved due to a shift to higher margin home andgarden products, and lower warehousing costs, in turn boostingprofit.

** PRIMUS TELECOMMUNICATIONS GROUP INC, $12.25, up24 pct (1209 ET)

The advanced communication solutions provider said onWednesday it sold its data center operations in Canada,Blackiron Data ULC, to Rogers Communications Inc for about C$200million ($195.15 million).

Primus provides domestic and international long-distance,Internet service, and Voice over Internet Protocol (VOIP). Thestock, trading nearly ten times its average 10-day volume, wasthe top percentage gainer on the New York Stock Exchange at 1209ET.

** SINOVAC BIOTECH LTD, $3.79, down 8.2 pct (1357ET)

The pharmaceutical company said fourth-quarter revenue fellto $19 million, from $21.1 million a year ago, as the companyrecorded no sales of its H1N1 flu vaccine in the quarter endedDec. 31.

** NORTHWEST BIOTHERAPEUTICS INC, $3.76, down 3.6pct (1356 ET)

The company entered into an agreement with ahealthcare-dedicated institutional investor for a registereddirect placement of $10 million of its common stock. Northwestalso said it will issue warrant coverage of 40 percent to theinvestor to buy shares of common stock at an exercise price of$4.29 per share.

** PEABODY ENERGY CORP, $20.57, up 8 pct (1356 ET)

** ARCH COAL INC, $5.04, up 11 pct (1404 ET)

The world's largest private sector coal miner reported asmaller-than-expected first-quarter loss on Thursday as itpushed to cut costs in a tough market, but revenue fell justshort of analysts' expectations.

Shares of peer Arch Coal were also up on the news.

** TAMINCO CORP, $14.25 (1215 ET)

The company's shares fell as much as 8 percent in theirtrading debut, valuing the company at nearly $900 million, wellbelow the price Apollo Global Management LLC paid toacquire the chemical maker from CVC Capital Partners in 2011.

** PEPSICO INC, $81.66, up 4 pct (1356 ET)

The maker of Pepsi sodas, Tropicana juices, Frito-Lay snacksand Quaker oatmeal reported better-than-expected first-quarterearnings, as price increases helped margins.

** GREENHILL & CO INC, $46.20, down 10 percent (1355ET)

The boutique investment bank reported first-quarter resultson Wednesday that widely missed estimates due to an investmentloss of $1.9 million compared to an investment gain of $9.4million in the year-earlier quarter.

At least four brokerages cut their price target on thecompany' stock.

** EAST WEST BANCORP, $23.08, down 4 pt (1354 ET)

The bank reported quarterly results on Wednesday that beatestimates, but net interest margin declined due to reducednon-covered loan portfolio yields.

BMO Capital Markets cut its rating on the company's stockto "market perform" from "outperform," while Sterne Ageedowngraded it to "neutral" from "buy" and lowered its pricetarget to $25 from $26.

** ESCO TECHNOLOGIES INC, $35.54, down 5.3 pct (1219ET)

Brokerage Oppenheimer & Co downgraded the engineeredproducts maker to "perform," saying project delays in the USwater market and fewer COOP deliveries lower Esco's near-termoutlook.

Wedbush Securities cut its target price to $48 from $50.

** SELECT COMFORT CORP, $18.04, up 3 pct (1357 ET)

Specialty mattress maker Select Comfort said it would revertto its earlier marketing strategy after a shift in advertisingreduced exposure of its products to already cautious customersand hit sales.

"While management clearly took their eye off the ball on themarketing, they are aggressively working to rectify thesituation and are seeing improvements in the business as aresult," Joan Storms of Wedbush Securities wrote in a note.

** UNIVERSAL FOREST PRODUCTS INC, $37.03, up 8.6pct (1353 ET)

The maker of wood and wood-alternative products reported itsfirst-quarter profit that beat analysts' estimates withincreased sales in each of its units due to 42.9 percentincrease in the lumber market.

** J.C. PENNEY, $15.03, up 1.7 pct (1259 ET)

** MACYS INC, $43.12, down 1.2 pct (1259 ET)

New York appeals court judge, Justice Richard Andrias, ruledthat J.C. Penney could sell Martha Stewart goods under a "JCPEveryday" label for now, pending an appeal by Macy's.

** COINSTAR INC, $54.47, down 3.5 (1353 ET)

Brokerage ITG Research lowered its revenue estimates for theoperator of Redbox video rental kiosks, citing weak March salestrends, the flyonthewall.com reported.

** DANAHER CORP, $58.22, down 2.5 pct (1353 ET)

The industrial and healthcare conglomerate's first-quarterprofit missed analysts' estimates as operating margin at itslargest business, life sciences & diagnostics, fell about 60basis points. The company also forecast second-quarter earningsbelow analysts' estimates.

** CORE LABORATORIES NV, $137.44, up 9 pct (1351 ET)

The oilfield services company reported its first-quarterprofit on Wednesday that topped analysts' expectations, asrevenue from its production enhancement operations, which dealswith increasing oilfield recovery factor, rose 11 percent.

** NOBLE CORP, $36.26, up 4 pct (1351 ET)

The owner of the world's third-largest offshore drillingfleet said Royal Dutch Shell Plc was in talks to extendits contract to use the Noble Discoverer beyond February 2014,underlining its long-term plans for the offshore Arctic.

GOLD STOCKS

** RANDGOLD RESOURCES LTD, $70.78, up 6 pct (1351ET)

** NEWMONT MINING CORP, $32.76, up 1.3 pct (1351 ET)

** ANGLOGOLD ASHANTI LTD, $17.90, up 2 pct (1351 ET)

** BARRICK GOLD CORP , $17.78, up 1 pct(1351 ET)

** FIRST MAJESTIC SILVER INC, $11.62, up 6 pct (1351ET)

** YAMANA GOLD INC, $11.53, up 4 pct (1351 ET)

** KINROSS GOLD CORP, $5.30, up 6 pct (1351 ET)

Gold rallied on Thursday in Europe after volatile Asiantrade saw prices slide towards two-year lows hit earlier in theweek, with strong physical buying set against exits fromexchange-traded funds. The sharp drop in prices has triggered aspate of buying in gold bars, coins and nuggets in Asia, whileU.S. gold coins have flown off dealers' shelves.

** EXACT SCIENCES CORP, $7.95, down 20.2 pct (1348ET)

The company said its molecular screening test for colorectalcancer met its goals in a large late-stage study, detecting thedisease in more than 90 percent of patients, but its sharesplummeted as much as 30 percent as the results were not asrobust as some were expecting.

** TRAVELZOO INC, $24.30, up 12 pct (1348 ET)

The online travel deals company reported a 7 percent rise infirst-quarter revenue, with its Europe travel business growing14 percent.

** THERAVANCE INC, $32.07, up 14.5 pct (1348 ET)

An advisory panel to the U.S. Food and Drug Administrationhas recommended that the agency approve an experimentaltreatment for smoking-related lung damage made by Britain'sGlaxoSmithKline Plc and Theravance.

** NOKIA OYJ , $3.17, down 11.5 pct (1316ET)

A big fall in sales of the company's basic phonesovershadowed a stronger performance from its Lumia smartphonesin the first quarter, and it said it expected operating marginsto deteriorate.

Chief Executive Stephen Elop said tougher competition wasthe main reason behind the fall in sales of regular mobilephones.

** PHILIP MORRIS INTERNATIONAL INC, $91.67, down 2.5pct (1347 ET)

The company, which sells Marlboro, reported first-quarterprofit that missed estimates as cigarette shipment volumesdeclined 6.5 percent.

** ULTRATECH INC, $31.70, down 13 pct (1405 ET)

The company, which manufactures chip-making equipment,reported lower-than-expected quarterly results.

** PRIVATEBANCORP INC, $18.80, up 8 pct (1347 ET)

The lender reported higher-than-expected quarterly profit,helped by mortgage banking and syndication fee revenue.Non-interest income rose 11 percent to $30.5 million.

** UNIPIXEL INC, $33.24, down 12.7 pct (1346 ET)

The LCD film maker said its offering of 1.2 million shareswas priced at $32 per share, a 16 percent discount to thestock's closing price on Wednesday.

** PPG INDUSTRIES INC, $140.16, up 6 pct (1345 ET)

The protective and decorative coatings maker reported aquarterly profit that beat analysts' estimates, helped by astrong demand in North America and Asia, and said it expects thepositive momentum in these geographies to continue in the secondquarter.

PPG also approved its quarterly dividend to 61 cents pershare from 59 cents per share.

** UNION PACIFIC CORP, $142.91, up 4.3 pct (1345 ET)

The No.1 U.S. railroad reported a strong first quarter ashigher freight rates offset a decline in coal shipments, and thecompany said it expects to ship more of the commodity in thecurrent quarter.

HEALTH INSURER STOCKS

** UNITEDHEALTH GROUP INC, $60.05, down 3 pct (1344ET)

** HUMANA INC, $72.49, down 3 pct (1344 ET)

** AETNA INC, $54.52, down 1.4 pct (1344 ET)

** WELLCARE HEALTH PLANS INC, $57.53, down 3 pct(1344 ET)

** MOLINA HEALTHCARE INC, $32.89, down 1 pct (1344ET)

** UNIVERSAL AMERICAN CORP, $8.78, down 2.2 pct(1344 ET)

** CENTENE CORP, $44.52, down 1.3 pct (1344 ET)

** WELLPOINT INC, $67.67, down 2 pct (1344 ET)

Shares of U.S. health insurers were down, a day after thelargest U.S. health insurer UnitedHealth reported bleakfirst-quarter profit due to lower government payments for itsprivate Medicare services and prescription plans for olderAmericans, and cut its 2013 revenue expectation.

** ALLISON TRANSMISSION HOLDINGS INC, $21.94, up3.7 pct (1341 ET)

The maker of fully-automatic transmissions said late onWednesday that investment funds affiliated with Carlyle Group LP and Onex Corp would not proceed with a secondaryoffering of Allison Transmission's common stock due to marketconditions.

** EBAY INC, $52.97, down 5.6 pct (1341 ET)

The e-commerce company gave a disappointing earningsforecast for the second quarter and said Europe was weak,pushing its shares lower in after-hours trade. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

More News
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.